Almeda Ventures Limited Partnership (TLV:AMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA 234.60
-5.20 (-2.17%)
At close: Aug 21, 2026
TLV:AMDA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | - | - | 0.01 | 0.02 | 0.02 | 0.01 |
Other Revenue | 10.74 | 2.47 | -3.03 | -0.31 | 0.89 | 1.59 |
| 10.74 | 2.47 | -3.02 | -0.29 | 0.91 | 1.6 | |
Revenue Growth | - | - | - | - | -43.21% | - |
Cost of Revenue | 0.01 | 0.01 | 0.03 | 0.04 | 0.06 | 0.04 |
Gross Profit | 10.73 | 2.46 | -3.04 | -0.33 | 0.85 | 1.56 |
Selling, General & Admin | 0.8 | 0.79 | 1.3 | 1.3 | 1.49 | 1.52 |
Operating Expenses | 0.8 | 0.79 | 1.3 | 1.3 | 1.49 | 1.52 |
Operating Income | 9.93 | 1.67 | -4.34 | -1.63 | -0.64 | 0.03 |
Interest Expense | -0.07 | -0 | -0 | -0.01 | -0 | -0.02 |
Interest & Investment Income | - | - | 0.05 | 0.05 | 0.06 | - |
Currency Exchange Gain (Loss) | -0.05 | -0.05 | 0.03 | -0.02 | -0.06 | 0.04 |
EBT Excluding Unusual Items | 9.84 | 1.62 | -4.27 | -1.61 | -0.64 | 0.05 |
Gain (Loss) on Sale of Investments | 0.13 | 0.13 | 0.07 | 0.03 | - | - |
Pretax Income | 9.97 | 1.75 | -4.2 | -1.58 | -0.64 | 0.05 |
Net Income | 9.97 | 1.75 | -4.2 | -1.58 | -0.64 | 0.05 |
Net Income to Common | 9.97 | 1.75 | -4.2 | -1.58 | -0.64 | 0.05 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 19 | 17 | 13 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 19 | 17 | 13 | 12 | 12 | 19 |
Shares Change | 29.44% | 33.19% | 2.50% | - | -33.81% | 570.10% |
EPS (Basic) | 0.54 | 0.10 | -0.33 | -0.13 | -0.05 | 0.00 |
EPS (Diluted) | 0.53 | 0.10 | -0.33 | -0.13 | -0.05 | 0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.98 | -0.98 | -1.09 | -1.13 | -1.46 | -1.29 |
Free Cash Flow Per Share | -0.05 | -0.06 | -0.09 | -0.09 | -0.12 | -0.07 |
Dividend Per Share | 0.094 | 0.094 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 99.94% | 99.76% | - | - | 93.94% | 97.43% |
Operating Margin | 92.46% | 67.73% | - | - | -70.45% | 2.13% |
Profit Margin | 92.81% | 70.90% | - | - | -70.67% | 3.26% |
Free Cash Flow Margin | -9.14% | -39.89% | - | - | -161.41% | -80.59% |
EBITDA | 9.94 | 1.69 | -4.28 | -1.55 | -0.56 | 0.1 |
EBITDA Margin | 92.53% | 68.34% | - | - | -61.96% | 6.14% |
D&A For EBITDA | 0.01 | 0.02 | 0.06 | 0.08 | 0.08 | 0.06 |
EBIT | 9.93 | 1.67 | -4.34 | -1.63 | -0.64 | 0.03 |
EBIT Margin | 92.46% | 67.73% | - | - | -70.45% | 2.13% |
Revenue as Reported | 10.74 | 2.47 | -3.02 | -0.29 | 0.91 | 1.6 |